Australian retail conglomerate Wesfarmers Ltd said on Thursday it bought a 19.3% stake in Australian Pharmaceutical Industries Ltd (API), in an attempt to block Sigma Healthcare Ltd’s rival proposed offer.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
